Interleukin-23 Increases Intestinal Epithelial Cell Permeability In Vitro

Nathan P. Heinzerling, Deborah Donohoe, Katherine Fredrich, David M. Gourlay, Jennifer L. Liedel

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background Breast milk has a heterogeneous composition that differs between mothers and changes throughout the first weeks after birth. The proinflammatory cytokine IL-23 has a highly variable expression in human breast milk. We hypothesize that IL-23 found in human breast milk is biologically active and promotes epithelial barrier dysfunction. Methods The immature rat small intestinal epithelial cell line, IEC-18, was grown on cell inserts or standard cell culture plates. Confluent cultures were exposed to human breast milk with high or low levels of IL-23 and barrier function was measured using a flux of fluorescein isothiocyanate–dextran (FD-70). In addition, protein and mRNA expression of occludin and ZO-1 were measured and immunofluorescence used to stain occludin and ZO-1. Results Exposure to breast milk with high levels of IL-23 caused an increase flux of FD-70 compared with both controls and breast milk with low levels of IL-23. The protein expression of ZO-1 but not occludin was decreased by exposure to high levels of IL-23. These results correlate with immunofluorescent staining of ZO-1 and occludin which show decreased staining of occludin in both the groups exposed to breast milk with high and low IL-23. Conversely, cells exposed to high IL-23 breast milk had little peripheral staining of ZO-1 compared with controls and low IL-23 breast milk. Conclusion IL-23 in human breast milk is biologically active and negatively affects the barrier function of intestinal epithelial cells through the degradation of tight junction proteins.

Original languageEnglish (US)
JournalEuropean Journal of Pediatric Surgery
DOIs
StateAccepted/In press - Feb 15 2015
Externally publishedYes

Fingerprint

Interleukin-23
Human Milk
Permeability
Epithelial Cells
Occludin
Staining and Labeling
In Vitro Techniques
Tight Junction Proteins
Fluorescein

Keywords

  • gut barrier
  • IL-23
  • necrotizing enterocolitis
  • tight junctions

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Surgery

Cite this

Interleukin-23 Increases Intestinal Epithelial Cell Permeability In Vitro. / Heinzerling, Nathan P.; Donohoe, Deborah; Fredrich, Katherine; Gourlay, David M.; Liedel, Jennifer L.

In: European Journal of Pediatric Surgery, 15.02.2015.

Research output: Contribution to journalArticle

Heinzerling, Nathan P. ; Donohoe, Deborah ; Fredrich, Katherine ; Gourlay, David M. ; Liedel, Jennifer L. / Interleukin-23 Increases Intestinal Epithelial Cell Permeability In Vitro. In: European Journal of Pediatric Surgery. 2015.
@article{9454aa5847b1452f83e60793da89761e,
title = "Interleukin-23 Increases Intestinal Epithelial Cell Permeability In Vitro",
abstract = "Background Breast milk has a heterogeneous composition that differs between mothers and changes throughout the first weeks after birth. The proinflammatory cytokine IL-23 has a highly variable expression in human breast milk. We hypothesize that IL-23 found in human breast milk is biologically active and promotes epithelial barrier dysfunction. Methods The immature rat small intestinal epithelial cell line, IEC-18, was grown on cell inserts or standard cell culture plates. Confluent cultures were exposed to human breast milk with high or low levels of IL-23 and barrier function was measured using a flux of fluorescein isothiocyanate–dextran (FD-70). In addition, protein and mRNA expression of occludin and ZO-1 were measured and immunofluorescence used to stain occludin and ZO-1. Results Exposure to breast milk with high levels of IL-23 caused an increase flux of FD-70 compared with both controls and breast milk with low levels of IL-23. The protein expression of ZO-1 but not occludin was decreased by exposure to high levels of IL-23. These results correlate with immunofluorescent staining of ZO-1 and occludin which show decreased staining of occludin in both the groups exposed to breast milk with high and low IL-23. Conversely, cells exposed to high IL-23 breast milk had little peripheral staining of ZO-1 compared with controls and low IL-23 breast milk. Conclusion IL-23 in human breast milk is biologically active and negatively affects the barrier function of intestinal epithelial cells through the degradation of tight junction proteins.",
keywords = "gut barrier, IL-23, necrotizing enterocolitis, tight junctions",
author = "Heinzerling, {Nathan P.} and Deborah Donohoe and Katherine Fredrich and Gourlay, {David M.} and Liedel, {Jennifer L.}",
year = "2015",
month = "2",
day = "15",
doi = "10.1055/s-0035-1551563",
language = "English (US)",
journal = "European Journal of Pediatric Surgery",
issn = "0939-7248",
publisher = "Thieme Medical Publishers",

}

TY - JOUR

T1 - Interleukin-23 Increases Intestinal Epithelial Cell Permeability In Vitro

AU - Heinzerling, Nathan P.

AU - Donohoe, Deborah

AU - Fredrich, Katherine

AU - Gourlay, David M.

AU - Liedel, Jennifer L.

PY - 2015/2/15

Y1 - 2015/2/15

N2 - Background Breast milk has a heterogeneous composition that differs between mothers and changes throughout the first weeks after birth. The proinflammatory cytokine IL-23 has a highly variable expression in human breast milk. We hypothesize that IL-23 found in human breast milk is biologically active and promotes epithelial barrier dysfunction. Methods The immature rat small intestinal epithelial cell line, IEC-18, was grown on cell inserts or standard cell culture plates. Confluent cultures were exposed to human breast milk with high or low levels of IL-23 and barrier function was measured using a flux of fluorescein isothiocyanate–dextran (FD-70). In addition, protein and mRNA expression of occludin and ZO-1 were measured and immunofluorescence used to stain occludin and ZO-1. Results Exposure to breast milk with high levels of IL-23 caused an increase flux of FD-70 compared with both controls and breast milk with low levels of IL-23. The protein expression of ZO-1 but not occludin was decreased by exposure to high levels of IL-23. These results correlate with immunofluorescent staining of ZO-1 and occludin which show decreased staining of occludin in both the groups exposed to breast milk with high and low IL-23. Conversely, cells exposed to high IL-23 breast milk had little peripheral staining of ZO-1 compared with controls and low IL-23 breast milk. Conclusion IL-23 in human breast milk is biologically active and negatively affects the barrier function of intestinal epithelial cells through the degradation of tight junction proteins.

AB - Background Breast milk has a heterogeneous composition that differs between mothers and changes throughout the first weeks after birth. The proinflammatory cytokine IL-23 has a highly variable expression in human breast milk. We hypothesize that IL-23 found in human breast milk is biologically active and promotes epithelial barrier dysfunction. Methods The immature rat small intestinal epithelial cell line, IEC-18, was grown on cell inserts or standard cell culture plates. Confluent cultures were exposed to human breast milk with high or low levels of IL-23 and barrier function was measured using a flux of fluorescein isothiocyanate–dextran (FD-70). In addition, protein and mRNA expression of occludin and ZO-1 were measured and immunofluorescence used to stain occludin and ZO-1. Results Exposure to breast milk with high levels of IL-23 caused an increase flux of FD-70 compared with both controls and breast milk with low levels of IL-23. The protein expression of ZO-1 but not occludin was decreased by exposure to high levels of IL-23. These results correlate with immunofluorescent staining of ZO-1 and occludin which show decreased staining of occludin in both the groups exposed to breast milk with high and low IL-23. Conversely, cells exposed to high IL-23 breast milk had little peripheral staining of ZO-1 compared with controls and low IL-23 breast milk. Conclusion IL-23 in human breast milk is biologically active and negatively affects the barrier function of intestinal epithelial cells through the degradation of tight junction proteins.

KW - gut barrier

KW - IL-23

KW - necrotizing enterocolitis

KW - tight junctions

UR - http://www.scopus.com/inward/record.url?scp=84930079309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930079309&partnerID=8YFLogxK

U2 - 10.1055/s-0035-1551563

DO - 10.1055/s-0035-1551563

M3 - Article

JO - European Journal of Pediatric Surgery

JF - European Journal of Pediatric Surgery

SN - 0939-7248

ER -